Serotonin Life Signaling This autumnal equinox PubMed science comes with a teaching abstract: it outlines the “several-fold” entouraging pathways of tryptophan, serotonin and kynurenine in creating a baby.
Tryptophan metabolism and dispositions and utilisation in pregnancy.
Badawy AA.
Biosci Rep. 2015 Sep 17. pii: BSR20150197. [Epub ahead of print] Review.
PMID: 26381576
Similar articles
Abstract
Tryptophan (Trp) requirements in pregnancy are several-fold:
(1) the need for increased protein synthesis by mother and for fetal growth and development;
(2) serotonin for signaling pathways;
(3) kynurenic acid for neuronal protection;
(4) quinolinic acid for NAD+ synthesis
(5) other kynurenines for suppressing fetal rejection.
These goals could not be achieved if maternal plasma [Trp] is depleted. Although plasma total (free + albumin-bound) Trp is decreased in pregnancy, free Trp is elevated. The above requirements are best expressed in terms of a Trp utilisation concept. Briefly, Trp is utilised as follows:
(1) In early and mid- pregnancy, emphasis is on increased maternal Trp availability to meet the demand for protein synthesis and fetal development, most likely mediated by maternal liver Trp 2,3-dioxygenase inhibition by progesterone and oestrogens.
(2) In mid- and late pregnancy, Trp availability is maintained and enhanced by the release of albumin-bound Trp by albumin depletion and non- esterified fatty acid (NEFA) elevation, leading to increased flux of Trp down the kynurenine pathway to elevate immunosuppressive kynurenines. An excessive release of free Trp could undermine pregnancy by abolishing T-cell suppression by kynurenines.
Detailed assessment of parameters of Trp metabolism and disposition and related measures (free and total Trp, albumin, NEFA, kynurenine and its metabolites and pro- and anti-inflammatory cytokines in maternal blood and, where appropriate, placental and fetal material) in normal and abnormal pregnancies may establish missing gaps in our knowledge of the Trp status in pregnancy and help identify appropriate intervention strategies.
Next Up: Tomorrow, 24 September, a Jonathan Magbie remembrance with some endocannabinoid pregnancy science.
Posted by Bryan W. Brickner
RSS Feed
